Pacer Advisors, Inc. Gilead Sciences, Inc. Transaction History

Pacer Advisors, Inc.

$38.6 Billion
Q1 2024

A detailed history of Pacer Advisors, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 6,324,871 shares of GILD stock, worth $434 Million. This represents 1.2% of its overall portfolio holdings.

Number of Shares

6,324,871

Previous 5,046,652 25.33%

Holding current value

$434 Million

Previous $409 Million 13.32%

% of portfolio

1.2%

Previous 1.3%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$71.58 - $87.29 $91.5 Million - $112 Million	1,278,219 Added 25.33%	6,324,871 $463 Million
Q4 2023 Jan 16, 2024	BUY	$73.27 - $83.09 $36.2 Million - $41 Million	493,920 Added 10.85%	5,046,652 $409 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $61.5 Million - $67 Million	831,107 Added 22.33%	4,552,732 $341 Million
Q2 2023 Jul 12, 2023	BUY	$76.01 - $86.7 $17.3 Million - $19.8 Million	228,183 Added 6.53%	3,721,625 $287 Million
Q1 2023 May 02, 2023	BUY	$77.31 - $88.08 $67.1 Million - $76.4 Million	867,597 Added 33.04%	3,493,442 $290 Million

Q4 2022 Feb 06, 2023	SELL	$62.32 - $89.47 $949,195 - $1.36 Million	-15,231 Reduced 0.58%	2,625,845 $225 Million
Q3 2022 Oct 18, 2022	BUY	$59.54 - $68.01 $6.84 Million - $7.82 Million	114,944 Added 4.55%	2,641,076 $163 Million
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $69 Million - $77.7 Million	1,195,509 Added 89.85%	2,526,132 $156 Million
Q1 2022 Apr 05, 2022	BUY	$57.92 - $72.58 $48.5 Million - $60.7 Million	836,884 Added 169.5%	1,330,623 $79.1 Million
Q4 2021 Feb 03, 2022	BUY	$64.88 - $73.64 $4.82 Million - $5.47 Million	74,236 Added 17.7%	493,739 $35.9 Million
Q3 2021 Oct 15, 2021	BUY	$67.69 - $73.03 $3.52 Million - $3.8 Million	52,013 Added 14.15%	419,503 $29.3 Million
Q2 2021 Jul 21, 2021	BUY	$63.47 - $69.35 $7.38 Million - $8.07 Million	116,320 Added 46.31%	367,490 $25.3 Million
Q1 2021 Apr 05, 2021	BUY	$60.0 - $68.46 $138,960 - $158,553	2,316 Added 0.93%	251,170 $16.2 Million
Q4 2020 Jan 20, 2021	SELL	$56.65 - $64.55 $350,833 - $399,758	-6,193 Reduced 2.43%	248,854 $14.5 Million
Q3 2020 Oct 19, 2020	SELL	$62.1 - $78.08 $910,448 - $1.14 Million	-14,661 Reduced 5.44%	255,047 $16.1 Million
Q2 2020 Jul 29, 2020	BUY	$72.34 - $84.0 $4.54 Million - $5.27 Million	62,776 Added 30.34%	269,708 $20.8 Million
Q1 2020 Apr 23, 2020	BUY	$62.63 - $80.22 $6.72 Million - $8.61 Million	107,270 Added 107.63%	206,932 $17.4 Million
Q4 2019 Feb 10, 2020	SELL	$61.62 - $67.78 $12.3 Million - $13.5 Million	-199,684 Reduced 66.71%	99,662 $6.48 Million
Q3 2019 Oct 10, 2019	BUY	$62.51 - $69.0 $1.13 Million - $1.24 Million	18,031 Added 6.41%	299,346 $19 Million
Q2 2019 Aug 12, 2019	BUY	$61.87 - $69.38 $1.28 Million - $1.44 Million	20,767 Added 7.97%	281,315 $19 Million
Q1 2019 Apr 10, 2019	BUY	$62.53 - $70.05 $13.1 Million - $14.7 Million	210,220 Added 417.7%	260,548 $16.9 Million
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $10.3 Million - $13.4 Million	-169,864 Reduced 77.14%	50,328 $3.15 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $3.79 Million - $4.2 Million	53,165 Added 31.83%	220,192 $17 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $1.98 Million - $2.3 Million	30,447 Added 22.29%	167,027 $11.8 Million
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $2.07 Million - $2.53 Million	28,476 Added 26.34%	136,580 $10.3 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $1.67 Million - $1.95 Million	23,402 Added 27.63%	108,104 $7.75 Million
Q3 2017 Nov 08, 2017	BUY	$72.11 - $85.47 $6.11 Million - $7.24 Million	84,702	84,702 $6.86 Million

Others Institutions Holding GILD

# of Institutions

1,884

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $86B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Account

Pacer Advisors, Inc. Gilead Sciences, Inc. Transaction History